Literature DB >> 17482136

Development of a chemiluminescent screening assay for detection of vascular endothelial growth factor receptor 1 ligands.

Victor Goncalves1, Benoit Gautier, Christiane Garbay, Michel Vidal, Nicolas Inguimbert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17482136     DOI： 10.1016/j.ab.2007.03.027

Source DB:  PubMed          Journal:  Anal Biochem        ISSN： 0003-2697            Impact factor:   3.365


× No keyword cloud information.
  8 in total

1.  A fluorescence polarization assay for identifying ligands that bind to vascular endothelial growth factor.

Authors:  Kimberly J Peterson; Jack D Sadowsky; Elizabeth A Scheef; Soumen Pal; Katerina D Kourentzi; Richard C Willson; Emery H Bresnick; Nader Sheibani; Samuel H Gellman
Journal:  Anal Biochem       Date:  2008-03-28       Impact factor: 3.365

2.  SH003 represses tumor angiogenesis by blocking VEGF binding to VEGFR2.

Authors:  Hyeong Sim Choi; Min Kyoung Kim; Kangwook Lee; Kang Min Lee; Youn Kyung Choi; Yong Cheol Shin; Sung-Gook Cho; Seong-Gyu Ko
Journal:  Oncotarget       Date:  2016-05-31

3.  DSGOST inhibits tumor growth by blocking VEGF/VEGFR2-activated angiogenesis.

Authors:  Hyeong Sim Choi; Kangwook Lee; Min Kyoung Kim; Kang Min Lee; Yong Cheol Shin; Sung-Gook Cho; Seong-Gyu Ko
Journal:  Oncotarget       Date:  2016-04-19

4.  Disrupting VEGF-VEGFR1 Interaction: De Novo Designed Linear Helical Peptides to Mimic the VEGF13-25 Fragment.

Authors:  Beatriz Balsera; M Ángeles Bonache; Marie Reille-Seroussi; Nathalie Gagey-Eilstein; Michel Vidal; Rosario González-Muñiz; María Jesús Pérez de Vega
Journal:  Molecules       Date:  2017-10-28       Impact factor: 4.411

5.  Design and synthesis of C-terminal modified cyclic peptides as VEGFR1 antagonists.

Authors:  Lei Wang; Nathalie Gagey-Eilstein; Sylvain Broussy; Marie Reille-Seroussi; Florent Huguenot; Michel Vidal; Wang-Qing Liu
Journal:  Molecules       Date:  2014-09-26       Impact factor: 4.411

6.  Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice.

Authors:  Florence Njau; Nelli Shushakova; Heiko Schenk; Vera Christine Wulfmeyer; Robin Bollin; Jan Menne; Hermann Haller
Journal:  PLoS One       Date:  2020-01-14       Impact factor: 3.240

7.  Synthesis, Characterization, and Biological Evaluation of a Dual-Action Ligand Targeting αvβ3 Integrin and VEGF Receptors.

Authors:  Simone Zanella; Michele Mingozzi; Alberto Dal Corso; Roberto Fanelli; Daniela Arosio; Marco Cosentino; Laura Schembri; Franca Marino; Marta De Zotti; Fernando Formaggio; Luca Pignataro; Laura Belvisi; Umberto Piarulli; Cesare Gennari
Journal:  ChemistryOpen       Date:  2015-07-02       Impact factor: 2.911

8.  Biophysical Studies of the Induced Dimerization of Human VEGF Receptor 1 Binding Domain by Divalent Metals Competing with VEGF-A.

Authors:  Jean-François Gaucher; Marie Reille-Seroussi; Nathalie Gagey-Eilstein; Sylvain Broussy; Pascale Coric; Bili Seijo; Marie-Bernard Lascombe; Benoit Gautier; Wang-Quing Liu; Florent Huguenot; Nicolas Inguimbert; Serge Bouaziz; Michel Vidal; Isabelle Broutin
Journal:  PLoS One       Date:  2016-12-12       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.